News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,511 Results
Type
Article (755)
Company Profile (1)
Press Release (7755)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (3084)
Career Advice (16)
Deals (385)
Drug Delivery (7)
Drug Development (1291)
Employer Resources (3)
FDA (258)
Job Trends (159)
News (4629)
Policy (356)
Tag
2027 Biotech Bay Standard (1)
Academia (31)
Accelerated approval (4)
ADA (3)
Alliances (960)
ALS (2)
Alzheimer's disease (18)
Antibody-drug conjugate (ADC) (9)
Approvals (266)
Artificial intelligence (16)
ASCO (3)
Autoimmune disease (7)
Automation (2)
Bankruptcy (10)
Best Places to Work (94)
BIOSECURE Act (1)
Biosimilars (20)
BioSpace Insights (1)
Biotechnology (1)
Bladder cancer (1)
Breast cancer (9)
Cancer (98)
Cardiovascular disease (9)
Career advice (15)
CDMO (2)
Cell therapy (7)
Clinical research (1112)
Collaboration (80)
Compensation (5)
COVID-19 (14)
C-suite (33)
Cystic fibrosis (7)
Data (84)
Depression (1)
Dermatology (3)
Diabetes (12)
Diagnostics (47)
Digital health (5)
Drug discovery (5)
Drug pricing (22)
Earnings (807)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (853)
Executive appointments (27)
FDA (296)
Frontotemporal dementia (1)
Funding (36)
Generative AI (2)
Gene therapy (9)
GLP-1 (73)
Government (61)
Guidances (6)
Healthcare (142)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (1)
Immunology and inflammation (10)
Immuno-oncology (1)
Indications (3)
Infectious disease (18)
Inflammatory bowel disease (5)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (2)
Interviews (4)
IPO (179)
IRA (10)
Job creations (69)
Job search strategy (15)
Kidney disease (6)
Labor market (2)
Layoffs (13)
Legal (83)
Licensing (1)
Lung cancer (40)
Lung diease (1)
Machine learning (2)
Management (1)
Manufacturing (15)
MASH (16)
Medical device (76)
Medtech (78)
Mergers & acquisitions (201)
Metabolic disorders (65)
mRNA (5)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (4)
Neuroscience (42)
NextGen: Class of 2026 (70)
Non-profit (36)
Now hiring (1)
Obesity (44)
Opinion (8)
Ovarian cancer (1)
Pain (1)
Parkinson's disease (3)
Patents (5)
Patient selection (1)
People (995)
Pharmacy benefit managers (3)
Phase 1 (263)
Phase 2 (452)
Phase 3 (419)
Pipeline (156)
Policy (17)
Postmarket research (115)
Preclinical (87)
Rare diseases (18)
Real estate (74)
Recruiting (1)
Regulatory (283)
Reports (1)
Research institute (30)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (10)
Series A (10)
Series B (6)
Special edition (1)
Startups (62)
Supply chain (2)
The Weekly (6)
Vaccines (12)
Venture capital (5)
Weight loss (35)
Date
Last 7 days (9)
Last 30 days (32)
Last 365 days (348)
2026 (273)
2025 (318)
2024 (413)
2023 (371)
2022 (665)
2021 (669)
2020 (584)
2019 (520)
2018 (377)
2017 (536)
2016 (489)
2015 (451)
2014 (374)
2013 (333)
2012 (325)
2011 (309)
2010 (336)
Location
Africa (20)
Alabama (1)
Arizona (4)
Asia (269)
Australia (66)
California (284)
Canada (11)
China (9)
Colorado (2)
Connecticut (30)
Europe (2320)
Florida (2)
Georgia (10)
Illinois (10)
India (2)
Indiana (10)
Japan (8)
Kansas (1)
Maryland (2)
Massachusetts (60)
Michigan (5)
Missouri (1)
Nevada (1)
New Hampshire (1)
New Jersey (13)
New York (19)
North Carolina (7)
Northern California (73)
Ohio (1)
Oklahoma (1)
Oregon (1)
Pennsylvania (8)
South America (21)
Southern California (157)
Tennessee (1)
Texas (6)
United States (483)
Utah (1)
Virginia (1)
Washington D.C. (2)
Washington State (17)
8,511 Results for "boehringer ingelheim fremont".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two other Phase 1 studies this year.
August 24, 2026
·
1 min read
·
Tristan Manalac
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
Envisagenics’ platform makes use of AI to screen and detect cancer-specific RNA alterations, which Boehringer Ingelheim wants to target through various precision treatment modalities, including multi-specific antibodies, antibody-drug conjugates and T cell engagers.
September 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies
· New research team expands capabilities at Boehringer’s U.S. R&D site in Ridgefield, Connecticut.
July 9, 2026
·
1 min read
Press Releases
Boehringer Ingelheim Spotlights Next Generation of Veterinary Researchers
August 10, 2026
·
5 min read
Obesity
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
Despite meeting the primary endpoints in a Phase 3 trial, shares of Zealand Pharma dropped in premarket trading Thursday as the up to 9.8% weight loss reflected inferior loss to that generated by competitors.
October 1, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million
September 29, 2026
·
5 min read
Press Releases
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
September 17, 2026
·
4 min read
Press Releases
Boehringer Ingelheim and AWARE launch new Stop Rabies project in Zimbabwe to help protect dogs and communities
September 23, 2026
·
4 min read
Press Releases
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
August 11, 2026
·
3 min read
Press Releases
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
September 24, 2026
·
3 min read
1 of 852
Next
